Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Orome
    Junior Member
    • Feb 2016
    • 4

    #1

    Illumina Pricing Schemes

    Hey sequencing hive mind,
    We are running a small, non-commercial NGS core (1x MiSeq, 1x NextSeq) with a weekly throughput of ~200 samples, almost entirely standard Illumina Nextera XT library prep.
    We have just started operation in February this year and are currently paying the full list price on Illumina consumables (library prep, indexing kits, flow cells).

    My question is: Does anyone have experience in terms of price negotiations with Illumina?
    At the moment I am not sure how to initiate negotiations because I don’t know what a good starting point would be.


    Thanks a ton!
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    As starting point you can ask for 25% off the list price and hope to settle on 10-15%.

    Comment

    • GenoMax
      Senior Member
      • Feb 2008
      • 7142

      #3
      Discounting may also be dependent on your "purchase capacity" over a year or so. You may need to start small and then renegotiate the discount annually.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      24 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...